ATE396277T1 - Verfahren zum nachweis einer milden beeinträchtigten glukosetoleranz oder insulin- hyposekretion - Google Patents

Verfahren zum nachweis einer milden beeinträchtigten glukosetoleranz oder insulin- hyposekretion

Info

Publication number
ATE396277T1
ATE396277T1 AT03715457T AT03715457T ATE396277T1 AT E396277 T1 ATE396277 T1 AT E396277T1 AT 03715457 T AT03715457 T AT 03715457T AT 03715457 T AT03715457 T AT 03715457T AT E396277 T1 ATE396277 T1 AT E396277T1
Authority
AT
Austria
Prior art keywords
myoinositol
glucose tolerance
impaired glucose
quantifying
sample
Prior art date
Application number
AT03715457T
Other languages
English (en)
Inventor
Masaru Yamakoshi
Takuji Kouzuma
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Application granted granted Critical
Publication of ATE396277T1 publication Critical patent/ATE396277T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Insulating Materials (AREA)
AT03715457T 2002-03-29 2003-03-27 Verfahren zum nachweis einer milden beeinträchtigten glukosetoleranz oder insulin- hyposekretion ATE396277T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002097121 2002-03-29

Publications (1)

Publication Number Publication Date
ATE396277T1 true ATE396277T1 (de) 2008-06-15

Family

ID=28671856

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03715457T ATE396277T1 (de) 2002-03-29 2003-03-27 Verfahren zum nachweis einer milden beeinträchtigten glukosetoleranz oder insulin- hyposekretion

Country Status (10)

Country Link
US (2) US7452687B2 (de)
EP (2) EP1491636B1 (de)
JP (2) JP4466912B2 (de)
CN (2) CN100526473C (de)
AT (1) ATE396277T1 (de)
AU (1) AU2003227237A1 (de)
DE (2) DE60321151D1 (de)
ES (2) ES2333181T3 (de)
HK (2) HK1070923A1 (de)
WO (1) WO2003083133A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4581994B2 (ja) 2002-12-09 2010-11-17 味の素株式会社 生体状態情報処理装置、生体状態情報処理方法、生体状態情報管理システム、プログラム、および、記録媒体
US7148041B2 (en) * 2003-09-25 2006-12-12 Allergan, Inc. Animal product free media and processes for obtaining a botulinum toxin
JPWO2006129513A1 (ja) 2005-05-30 2008-12-25 味の素株式会社 肝疾患評価装置、肝疾患評価方法、肝疾患評価システム、肝疾患評価プログラムおよび記録媒体
WO2009001862A1 (ja) 2007-06-25 2008-12-31 Ajinomoto Co., Inc. 内臓脂肪蓄積の評価方法
WO2009054350A1 (ja) * 2007-10-25 2009-04-30 Ajinomoto Co., Inc. 耐糖能異常の評価方法
JP5722548B2 (ja) * 2010-03-31 2015-05-20 シーシーアイ株式会社 バイオセンサ
GB201017547D0 (en) * 2010-10-18 2010-12-01 Univ Cardiff Method and device for the detection of sulphur containing species
JP5815362B2 (ja) 2011-10-17 2015-11-17 シスメックス株式会社 耐糖能分析装置、耐糖能分析システム及びコンピュータプログラム
RU2498306C2 (ru) * 2011-12-23 2013-11-10 Федеральное государственное бюджетное учреждение "Государственный научно-исследовательский центр профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "ГНИЦПМ" Минздрава России) Способ раннего выявления высокого риска развития нарушения толерантности к глюкозе на фоне приема метопролола у больных стабильной стенокардией напряжения
CN102645414B (zh) * 2012-04-06 2014-04-02 上海蓝怡科技有限公司 测定尿液肌醇的试剂盒
JP2015099094A (ja) * 2013-11-19 2015-05-28 国立大学法人徳島大学 ３次元イムノクロマトグラフィ方式を用いた糖尿病検査診断用シート、糖尿病検査診断用デバイス、およびミオイノシトールの検出方法
CN103937870B (zh) * 2014-04-25 2016-05-25 中国人民解放军第四军医大学 一种连续检测胰岛素敏感性的方法
JP6401297B2 (ja) * 2014-12-25 2018-10-10 株式会社日立製作所 インスリン分泌能分析装置、当該装置を備えるインスリン分泌能分析システム及びインスリン分泌能分析方法
CN115901909A (zh) * 2021-08-12 2023-04-04 西南医科大学附属医院 一种定量检测血液中肌肉肌醇的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
DE69130961T2 (de) 1990-09-18 1999-08-12 Asahi Kasei Kogyo K.K., Osaka Myo-Inositoldehydrogenase
JPH0661278B2 (ja) 1990-09-18 1994-08-17 旭化成工業株式会社 ミオイノシトールの高感度定量法および定量用組成物
JP3251976B2 (ja) 1992-06-23 2002-01-28 旭化成株式会社 ミオ・イノシトールデヒドロゲナーゼを生産する実質上純粋な微生物
EP0969098A4 (de) * 1997-03-26 2003-05-21 Asahi Chemical Ind Hochsensitive methode zum bestimmen von chrio-irositol und zusammensetzungen für die versuchsanordnung
AU4091499A (en) 1998-05-21 1999-12-06 Insmed Pharmaceuticals, Inc. (myo)-inositol as a predictor of glycemic control in mammals
CA2291912A1 (en) * 1998-12-11 2000-06-11 Kyowa Medex Co., Ltd. Method and reagent for quantitative determination of 1,5-anhydroglucitol
JP4412780B2 (ja) * 1998-12-11 2010-02-10 協和メデックス株式会社 １，５−アンヒドログルシトールの定量法および定量試薬
JP2000298131A (ja) 1999-04-14 2000-10-24 Ryuzo Kawamori 前糖尿病状態の検出方法
JP3975279B2 (ja) 1999-11-01 2007-09-12 旭化成ファーマ株式会社 糖尿病予備群の検査方法
KR100882078B1 (ko) 2003-07-11 2009-02-10 파나소닉 주식회사 디스플레이 세트의 병렬처리를 수행할 수 있는 재생장치, 기록매체, 기록방법, 재생방법, 및 컴퓨터 판독가능한 기록매체
JP5350380B2 (ja) * 2007-07-18 2013-11-27 マーベル ワールド トレード リミテッド 複数のクライアント局に対する独立したデータを同時ダウンリンク伝送するアクセスポイント

Also Published As

Publication number Publication date
AU2003227237A1 (en) 2003-10-13
HK1070923A1 (en) 2005-06-30
ES2302919T3 (es) 2008-08-01
JPWO2003083133A1 (ja) 2005-08-04
JP4466912B2 (ja) 2010-05-26
JP2010094135A (ja) 2010-04-30
DE60330411D1 (de) 2010-01-14
CN1650025A (zh) 2005-08-03
EP1923469A1 (de) 2008-05-21
US20050214885A1 (en) 2005-09-29
ES2333181T3 (es) 2010-02-17
JP5004367B2 (ja) 2012-08-22
US7452687B2 (en) 2008-11-18
EP1491636A1 (de) 2004-12-29
US20090042279A1 (en) 2009-02-12
CN100526473C (zh) 2009-08-12
EP1923469B1 (de) 2009-12-02
EP1491636B1 (de) 2008-05-21
DE60321151D1 (de) 2008-07-03
HK1114532A1 (en) 2008-10-31
EP1491636A4 (de) 2006-07-26
WO2003083133A1 (fr) 2003-10-09
CN101565740A (zh) 2009-10-28

Similar Documents

Publication Publication Date Title
HK1070923A1 (en) Method of detecting mild impaired glucose tolerance or insulin hyposecretion
WO2004059294A3 (en) Improved luciferase-based assays
AR016241A1 (es) Un reactivo para medir una concentracion de un analito y una tira reactiva seca para determinar la presencia y la cantidad de un analito, en un fluido biologico que contiene hemoglobina
DE69735127D1 (de) Enzymsensor
NO20060599L (no) Metode for produksjon av cellulolytiske og hemicellulolytiske enzymer ved anvendelse av destillasjonsrester fra etanolfermentering av enzymatiske hydrolysater av (ligno) cellulosematerialer
WO2001000865A3 (en) Amperometric sensor
BR0213936A (pt) Ensaios de ciclização enzimáticos para homocisteìna e cistationina
PE20050079A1 (es) Derivados de pirrolidona como inhibidores de maob
DE50311003D1 (de) Verbundkeramikkörper sowie verfahren zum herstellen eines solchen
DE60314990D1 (de) Verfahren zur quantifizierung von glykosyliertem protein unter verwendung einer redoxreaktion sowie eines quantifizierungskits
DE3587981D1 (de) Substrate für Hydrolasen, Verfahren zu ihrer Herstellung und ihre Verwendung.
BR9916458A (pt) Método de varredura de compostos candidatos para suscetibilidade ao metabolismo oxidativo
NO20071564L (no) Fremgangsmate for a bestemme konsentrasjonen av analytter i prover ved direkte formidling av enzymer
GB2436990A (en) Amperometric sensor and method for the detection of gaseous analytes comprising a working electrode comprising edge plane pyrolytic graphite
EA200702222A1 (ru) Новый способ проектирования и обработки трубных соединений
JP2003513280A5 (de)
DE3852889D1 (de) Test von salicylaten oder reduzierten pyridin-nukleotiden.
WO2007029245A3 (en) Electrochemical method and system for detection of trace explosives
EP0148950A4 (de) Verfahren zur herstellung von bilirubin-oxidase.
WO2004005888A3 (en) Method for metal analysis and speciation and biosensor for effecting the method
WO2001033187A3 (en) Enzymatic cycling assays for homocysteine and cystathionine
EP1515143A4 (de) Testverfahren mit einer oxidations-/reduktionsreaktion mit formazan
WO2001077670A3 (en) Homocysteine assay
EP0882800A3 (de) Verfahren und Reagenz zur Bestimmung von direktem Bilirubin
WO2005003369A3 (en) Methods for detection and quantification of analytes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties